Literature DB >> 3840493

A long term clinical, immunological, and histological follow-up study of patients with goitrous chronic lymphocytic thyroiditis.

Y Hayashi, H Tamai, S Fukata, Y Hirota, S Katayama, K Kuma, L F Kumagai, S Nagataki.   

Abstract

Goiter size, thyroid function, antimicrosomal and antithyroglobulin antibodies, and thyroid histology were compared in 43 patients with goitrous chronic lymphocytic thyroiditis (Hashimoto's disease) confirmed by biopsy before and after an interval of 10-20 yr. Although all were given thyroid hormone therapy, 13 patients took it infrequently, and are considered untreated. Among these 13 patients, 5 (38%) became hypothyroid, and 1 became thyrotoxic. Goiter size decreased in 17 (57%) of 30 patients during therapy and in 3 (23%) of 13 untreated patients, and the incidence of reduction was greater in treated than in untreated patients (P less than 0.05). However, in 13 (43%) of the patients, goiter size did not decrease even during treatment. Titers of antithyroid antibodies decreased in only 8 (21%) of 38 patients. There was no significant correlation between changes in antibodies and the size of goiter, and treatment with thyroid hormone did not decrease the titers of antibodies. In patients whose goiters were initially diffusely enlarged and regressed significantly in size during the follow-up period, the initial biopsies showed histological changes in diffuse lymphocytic infiltration and diffuse epithelial changes. Comparative studies of histological differences between patients who were treated with thyroid hormone and those who were not were made in the patients who had no change in goiter size during the observation period, which was greater than 10 yr. The histological changes were similar in both groups at the beginning of the study, and no significant histological changes during the period of greater than 10 yr were found in either group. In one patient who developed thyrotoxicosis after 20 yr and was rebiopsied, the histological picture was that of thyroid hyperplasia and lymphocytic thyroiditis. These data indicate that goitrous chronic lymphocytic thyroiditis changes little as a function of time in many patients regardless of whether thyroid hormone is administered.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840493     DOI: 10.1210/jcem-61-6-1172

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Thyroid cancer, thyroiditis and dietary iodine: a review based on the Salta, Argentina model.

Authors:  H Rubén Harach; Gustavo A Ceballos
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

2.  A nonclassical model of autoimmune hypothyroidism.

Authors:  Patrizio Caturegli; Hiroaki Kimura
Journal:  Thyroid       Date:  2010-01       Impact factor: 6.568

3.  Hypothyroidism to hyperthyroidism: an immunological pendulum swing from two extreme poles - a case series.

Authors:  Antoni R Kafrouni Gerges; Sara N Clark; Hassan Shawa
Journal:  BMJ Case Rep       Date:  2019-04-05

4.  L-thyroxine therapy induces a fall of thyroid microsomal and thyroglobulin antibodies in idiopathic myxedema and in hypothyroid, but not in euthyroid Hashimoto's thyroiditis.

Authors:  L Chiovato; C Marcocci; S Mariotti; A Mori; A Pinchera
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

5.  A small subgroup of Hashimoto's thyroiditis is associated with IgG4-related disease.

Authors:  Friedrich Jokisch; Irene Kleinlein; Bernhard Haller; Tanja Seehaus; Heinrich Fuerst; Marcus Kremer
Journal:  Virchows Arch       Date:  2015-12-15       Impact factor: 4.064

6.  Pathogenetic role of thyrotropin receptor antibody in the development of hyperthyroidism following primary hypothyroidism.

Authors:  Y K Shong; B Y Cho; S K Hong; H K Lee; C S Koh; H K Min
Journal:  Korean J Intern Med       Date:  1989-07       Impact factor: 2.884

7.  L-thyroxine stabilizes autoimmune inflammatory process in euthyroid nongoitrous children with Hashimoto's thyroiditis and type 1 diabetes mellitus.

Authors:  Katarzyna Korzeniowska; Przemyslawa Jarosz-Chobot; Agnieszka Szypowska; Anna Ramotowska; Wojciech Fendler; Barbara Kalina-Faska; Agnieszka Szadkowska; Wojciech Mlynarski; Malgorzata Mysliwiec
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013

8.  Clinical and Immunological Aspects in Hashimoto's Thyroiditis.

Authors:  Adriana Rosca; Victor Dumitrascu; Daniela Grecu; Ioana Zosin; Mihaela David
Journal:  EJIFCC       Date:  2003-12-02

9.  Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis.

Authors:  A Gasbarri; S Sciacchitano; A Marasco; M Papotti; A Di Napoli; A Marzullo; P Yushkov; L Ruco; A Bartolazzi
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.